Simultaneous Determination of Fosinopril and Its Active Metabolite Fosinoprilat in Human Plasma by LC-MS/MS
CUI Shuang-jin,FENG Fang,MA Ming,LIU Han
DOI: https://doi.org/10.3321/j.issn:1000-5048.2007.04.014
2007-01-01
Abstract:Aim:To establish a LC-MS/MS method for the simultaneous determination of plasma fosinopril and its major active metabolite fosinoprilat concentrations in human pharmacokinetic studies.Methods:After adding zaleplon(internal standard),plasma samples were extracted by ether-dichloromethane(3∶1)and then determined by LC-MS/MS.The separation was carried out on a Lichrospher C8(4.6 mm×250 mm,5 μm)at 25 ℃,with gradient elution at a flow rate of 1.0 mL/min.Methanol was used as eluent A and 10 mmol/L ammonium acetate aqueous was used as eluent B.The gradient procedure was as follows:from 0 min to 2.0 min,40% B;from 2.01 min to 10.0 min,40% B.HPLC-MS/MS was monitored in the mode of selected reaction monitoring(SRM)mode.A single oral dose of 20-mg fosinopril sodium tablets was administered to 20 healthy subjects.Results:Linearity between the observed response and the concentration was found with fosinopril and fosinoprilat over the concentration range of 0.1~15 ng/mL and 1.0~700 ng/mL for fosinopril and fosinoprilat,respectively.Intra-day and inter-day precisions(expressed as RSD)in the method were less than 3.7% and 6.9% for fosinopril and less than 2.4% and 5.2% for fosinoprilat,respectively.For fosinopril,the main pharmacokinetic parameters t1/2,tmax and cmax were found to be(2.72±1.75)h,(1.21±0.42)h and(4.61±2.34)ng/mL,respectively.For fosinoprilat,the main pharmacokinetic parameters t1/2,tmax and cmax were(7.25±0.81)h,(3.74±0.87)h and(409.43±136.28)ng/mL,respectively.Conclusion:The assay was proved to be sensitive,accurate and convenient.It can be applied to study the pharmacokinetics and bioavailability of fosinopril and fosinoprilat formulations in humans.